A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some families around the world an unlikely lifeline.

The White House recently endorsed monitoring sewage for evidence of drug use. Critics fear such efforts could violate privacy and stigmatize neighborhoods.

Following the pandemic, the federal government is spending $150 million on new technology to ensure clean indoor air. Here’s what scientists are pursuing.

It’s hot in North America in June, but fans are griping that the breaks that have been added to each half are an excuse for the networks to show more ads.

The oldest known cases, discovered among hunter-gatherers in Siberian graves, contradict the theory that the disease once was mild.

The State Department is taking over much of the control of global health initiatives, for which critics say the department does not have the expertise.

Five stories show the hurdles that people with psychological diagnoses face when considering parenthood.

As tech giants rush to build infrastructure, some residents who live near data centers say a constant low-frequency vibration is ruining their health and homes.

Others who were in the facility have been allowed to return to their homes in recent weeks for monitoring by local health officials.

With support from Markwayne Mullin and Robert F. Kennedy Jr., the kratom industry is pursuing a potentially lucrative policy. Mr. Mullin owns equity in a company that could benefit.

A new study of bilingual speakers suggests that a single “grammatical engine” in the brain can power multiple languages at once.

The health secretary is trying to restart the work of a panel that advises the government on vaccines, after a judge froze its decisions and prevented it from meeting.